BrainsWay (BWAY) announce its underwriting of two new Continuing Medical Education courses designed to expand clinician knowledge and confidence in the use of Transcranial Magnetic Stimulation. These online, no-cost CME activities aim to deepen understanding of the robust clinical evidence supporting TMS, clarify distinctions between Deep TMS-a proprietary BrainsWay technology-and first-generation figure-8 coil TMS, and provide practical guidance for integrating TMS into clinical practice. Supported through independent educational grants from BrainsWay, the courses are led by an esteemed faculty of thought leaders in the field of psychiatry and brain stimulation: “Data-Driven Insights for Incorporating Transcranial Magnetic Stimulation Into Your Practice”: This course equips learners with evidence-based data supporting TMS, highlights distinctions in TMS technologies, and explores the growing role of TMS in treating mental health and addiction conditions. “Case-Based Patient Application Pathways for Transcranial Magnetic Stimulation”: This activity focuses on practical, case-driven strategies to identify suitable patients for TMS and integrate treatment into comprehensive care plans.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWAY:
- BrainsWay Announces Positive Results from Accelerated Deep TMS Study for Depression
- Brainsway announces preliminary results from Accelerated Deep TMS study
- Brainsway announces Gold Sponsorship at Clinical TMS Society Annual Meeting
- BrainsWay Invests $5 Million in Stella MSO to Boost Mental Health Access
- Brainsway announces $5M minority-stake investment in Stella MSO